Anticoagulation Therapy in Microsurgery: A Review

Journal of Hand Surgery

Volumn 31, Issue 5, 2006, Pages 836-846

  Askari, Morad ^a,b   Fisher, Christine ^a,b   Weniger, Frederick G ^a,b   Bidic, Sean ^a,b   Lee, W P Andrew ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

anticoagulation; flap; heparin; Microsurgery; thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CHLORPROMAZINE; CYCLOOXYGENASE 2 INHIBITOR; DALTEPARIN; DESMOPRESSIN; DEXTRAN; DEXTRAN 40; DIPYRIDAMOLE; ENOXAPARIN; FIBRINOLYTIC AGENT; HEPARIN; IBUPROFEN; ILOPROST; INDOMETACIN; KETOROLAC; LOW MOLECULAR WEIGHT HEPARIN; PENTOXIFYLLINE; RECOMBINANT HIRUDIN; RECOMBINANT TISSUE FACTOR PATHWAY INHIBITOR; SEDATIVE AGENT; STREPTOKINASE; TICLOPIDINE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ACUTE KIDNEY FAILURE; ANAPHYLAXIS; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLOOD CLOTTING; BRAIN EDEMA; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG RESEARCH; DRUG USE; GASTROINTESTINAL HEMORRHAGE; GLOMERULONEPHRITIS; HEMATOMA; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; KIDNEY TUBULE DISORDER; LUNG EDEMA; MICROSURGERY; NEPHROTOXICITY; NONHUMAN; PEROPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SURGICAL TECHNIQUE; THROMBOCYTE DYSFUNCTION; THROMBOSIS; THROMBOSIS PREVENTION; TREATMENT FAILURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VASCULAR PATENCY; VEIN THROMBOSIS;

ANIMALS; ANTICOAGULANTS; HAND; HUMANS; MICROSURGERY; REPLANTATION; SURGICAL FLAPS; THROMBOSIS;

EID: 33646495591     PISSN: 03635023     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhsa.2006.02.023     Document Type: Article

References (100)

1. Hui K, Feng LJ, Piccolo N, et al. The rat femoral vein anastomosis: an assessment of its patency rate. In: Proceedings of the American Society for Reconstructive Microsurgery San Antonio, TX: September 12-13, 1991.
2. Hidalgo D.A., Disa J.J., Cordeiro P.G., and Hu Q.Y. A review of 716 consecutive free flaps for oncologic surgical defects. refinement in donor-site selection and technique. Plast Reconstr Surg 102 (1998) 722
3. Ichinose A., Tahara S., Terashi H., Nomura T., and Omori M. Short-term postoperative flow changes after free radial forearm flap transfer. possible cause of vascular occlusion. Ann Plast Surg 50 (2003) 160
4. Khouri R.K., Cooley B.C., Kunselman A.R., Landis J.R., Yeramian P., Ingram D., et al. A prospective study of microvascular free-flap and outcome. Plast Reconstr Surg 102 (1998) 711
5. Khouri R.K., and Shaw W.W. Reconstruction of the lower extremity with microvascular free flaps. a 10-year experience with 304 consecutive cases. J Trauma 29 (1989) 1086
6. Chien W., Varvares M.A., and Deschler D.G. Effects of aspirin and low-dose heparin in head and neck reconstruction using microvascular free flaps. Laryngoscope 115 (2005) 973
7. Ahmad T.S., Musa G., and Lee J.K. A review of free flap failures in the university hospital, Kuala Lumpur. Ann Acad Med Singapore 26 (1997) 840
8. Li X., and Cooley B.C. Effect of anticoagulation and inhibition of platelet aggregation on arterial versus venous microvascular thrombosis. Ann Plast Surg 35 (1995) 165
9. Kroll S.S., Schusterman M.A., Reece G.P., Miller M.J., Evans G.R., Robb G.L., and Baldwin B.J. Timing of pedicle thrombosis and flap loss after free-tissue transfer. Plast Reconstr Surg 98 (1996) 1230
10. Cooley B.C., Ruas E.J., and Wilgis E.F. Scanning electron microscopy of crush/avulsion arterial trauma. effect of heparin and aspirin administration. Microsurgery 8 (1987) 11
11. Miller M.J., Shusterman M.A., Reece G.P., and Kroll S.S. Interposition vein grafting in head and neck reconstructive microsurgery. J Reconstr Microsurg 9 (1993) 245
12. Oliva A, Yim K, Lineaweaver WE, et al. Vein grafting in microsurgical transplantation. Presented at the 59th Annual Scientific Meeting of the American Society of Plastic and Reconstructive Surgeons, Boston, MA: October 21-24, 1990.
13. Adams Jr. W.P., Ansari M.S., Hay M.T., Tan J., Robinson Jr. J.B., Friedman R.M., and Rohrich R.J. Patency of different arterial and venous end-to-side microvascular techniques in a rat model. Plast Reconstr Surg 105 (2000) 156
14. Khouri R.K., Sherman R., Buncke H.J., Feller A.M., Hovius S., Benes C.O., et al. A phase II trial of intraluminal irrigation with recombinant human tissue factor pathway inhibitor to prevent thrombosis in free flap surgery. Plast Reconstr Surg 107 (2001) 408
15. Jacobson II J.H., and Suarez E.L. Microsurgery in anastomosis of small vessels. Surg Forum 11 (1960) 243
16. Yii N.W., Evans G.R.D., Miller M.J., Reece G.P., Langstein H., Chang D., et al. Thrombolytic therapy. what is its role in free flap salvage?. Ann Plast Surg 46 (2001) 601
17. Davis D.M. A world survey of anticoagulation practice in clinical microvascular surgery. Br J Plast Surg 35 (1982) 96
18. Johnson P.C., and Barker J.H. Thrombosis and antithrombotic therapy in microvascular surgery. Clin Plast Surg 19 (1992) 799
19. Das S.K., and Miller J.H. Current status of topical antithrombotic agents in microvascular surgery. Microsurgery 15 (1994) 630
20. Ketchman L.D. Pharmacological alterations in the clotting mechanism. use in microvascular surgery. J Hand Surg 3 (1978) 407
21. Stockmans F., Stassen J.M., Vermylen J., Hoylaerts M.F., and Nystrom A. A technique to investigate mural thrombosis formation in arteries and vein: II. Effects of aspirin, heparin, r-hirudin and G-4120. Ann Plast Surg 38 (1997) 63
22. Bettigole R.E. Drugs acting on the blood and blood-forming organs. In: Smith C.M. (Ed). Textbook of pharmacology (1992), W.B. Saunders Company, Philadelphia 784-801
23. Hirsh J., Warkentin T.E., Shaughnessy S.G., et al. Heparin and low-molecular-weight heparin. mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 119 suppl (2001) 64S
24. Wolf H. Low-molecular-weight heparin. Med Clin North Am 78 (1994) 733
25. Tangphao O., Chalon S., Moreno H.J., Abiose A.K., Blaschke T.F., and Hoffman B.B. Heparin-induced vasodilation in human hand of veins. Clin Pharmacol Ther 66 (1999) 232
26. Hemker H.C., Beguin S., and Kakkar V.V. Can the haemorrhagic component of heparin be identified? Or an attempt at clean thinking on a dirty drug. Haemostasis 26 (1996) 117
27. Pugh C.M., Dennis II R.H., and Massac E.A. Evaluation of intraoperative anticoagulants in microvascular free-flap surgery. J Natl Med Assoc 88 (1996) 655
28. Fabris F., Luzzatto G., Stefani P.M., Giromali B., Cella G., and Girolami A. Heparin-induced thrombocytopenia. Haematologica 85 (2000) 72
29. Nelson-Piercy C. Hazards of heparin. allergy, heparin-induced thrombocytopenia and osteoporosis. Baillieres Clin Obstet Gynaecol 11 (1997) 489
30. Warkentin T.E., Chong B.H., and Greincher A. Heparin-induced thrombocytopenia. toward consensus. Thromb Haemost 79 (1998) 1
31. Yokokawa K., Mankus R., and Saklayen M. Increased nitric oxide production in patients with hypotension during hemodialysis. Ann Intern Med 123 (1995) 35
32. Seltzer J.I., and Gerson J.I. Decrease in arterial pressure following heparin injection prior to cardiopulmonary bypass. Acta Anaesth Scand 23 (1979) 575
33. Casthely P.A., Yoganathan D., Karyanis B., Salem M., Yoganathan T., Komer C., et al. Histamine blockade and cardiovascular changes following heparin administration during cardiac surgery. J Cardiothorac Anesth 4 (1990) 711
34. Malm K., Dahlbäck B., and Arnljots B. Low molecular-weight heparin (Dalteprin) effectively prevents thrombosis in a rat model of deep arterial injury. Plast Reconstr Surg 111 (2003) 1659
35. Turpie A.G.G. State of the art-a journey through the world of antithrombotic therapy. Semin Thromb Hemost 28 suppl 3 (2002) 3
36. Rooks M.D., Rodriguez Jr. J., Blechner M., Zusmanis K., and Hutton W. Comparative study of intraarterial and intravenous anticoagulants in microvascular anastomosis. Microsurgery 15 (1994) 123
37. Kort W.J., de Kam J., and Westbroek D.L. Per-operative topical administration of ZK 36,374 (Iloprost) acts favorably on patency of small artery anastomoses in rats. Microsurgery 8 (1987) 17
38. Hudson D.A., Engelbrecht G., and Duminy F.J. Another method to prevent venous thrombosis in microsurgery. an in situ venous catheter. Plast Reconstr Surg 105 (2000) 999
39. Reichel C.A., Croll G.H., and Pucckett C.L. A comparison of irrigation solutions for microanastomoses. J Hand Surg 13A (1988) 33-36
40. Fu K., Izquierdo R., Walenga J.M., and Fareed J. Comparative study on the use of anticoagulants heparin and recombinant hirudin in a rabbit traumatic anastomosis model. Thromb Res 78 (1995) 421
41. Khouri R.K., Koudsi B., Fu K.D., Ornberg R.L., and Wun T. Prevention of thrombosis by topical application of tissue factor pathway inhibitor in a rabbit model of vascular trauma. Ann Plast Surg 30 (1993) 398-404
42. Sinclair S. The importance of topical heparin in microvascular anastomoses. a study in the rat. Br J Plast Surg 33 (1980) 422
43. Yan J.G., Yousif N.J., and Siegesmund K.A. Irrigation pressure and vessel injury during microsurgery. a qualitative study. J Reconstr Microsurg 20 (2004) 399
44. Bijsterveld N.R., Hettiarachchi R., Peters R., Prins M.H., Levi M., and Buller H.R. Low-molecular weight heparin in venous and arterial thrombotic disease. Thromb Haemost 82 suppl 1 (1999) 139
45. Nader H.B., Walenga J.M., Berkowitz S.D., Ofosu F., Hoppensteadt D.A., and Cella G. Preclinical differentiation of low molecular weight heparins. Semin Thromb Hemost 25 suppl 3 (1999) 63
46. Roque M., Rauch U., Reis E.D., Chesebro J.H., Fuster V., and Badimon J.J. Comparative study of antithrombotic effect of a low molecular weight heparin and unfractionated heparin in an ex vivo model of deep arterial injury. Thromb Res 98 (2000) 499
47. Ritter E.F., Cronan J.C., Rudner A.M., Serafin D., and Klitzman B. Improved microsurgical anastomotic patency with low molecular weight heparin. J Reconstr Microsurg 14 (1998) 331
48. Zhang B., Dougan P., and Wieslander J.B. A comparison of the early antithrombotic effects between low molecular weight heparin in small arteries following a severe trauma. an experimental study. Ann Plast Surg 31 (1993) 255
49. Green D., Hirsh J., Heit J., Prins M., Davidson B., and Lensing A.W. Low molecular weight heparin. a critical analysis of clinical trials. Pharmacol Rev 46 (1994) 89
50. Warkentin T.E., Levine M.N., Hirsh J., Horsewood P., Roberts R.S., Gent M., and Kelton J.G. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 332 (1995) 1330
51. Dietrich C.P., Shinjo S.K., Moreas F.A., Castro R.A., Mendes A., Gouvea T.C., and Nader H.B. Structural features and bleeding activity of commercial low molecular weight heparins. neutralization by ATP and protamine. Semin Thromb Hemost 25 suppl 3 (1999) 43
52. Dunn C.J., and Sorkin E.M. Dalteparin sodium. a review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders. Drugs 52 (1996) 276
53. Ertas N.M., Goldman C., and Siemionow M. Dose response of enoxaparin at the cremaster muscle flap microcirculation. Microsurgery 25 (2005) 147
54. Ljungström K.-G. The antithrombotic efficacy of dextran. Acta Chir Scand 543 suppl (1988) 26
55. Johnson P.C. Platelet-mediated thrombosis in microvascular surgery. new knowledge and strategies. Plast Reconstr Surg 86 (1990) 359
56. Atik M. Dextran 40 and dextran 70. a review. Arch Surg 94 (1967) 664
57. Gelin L.E. Effect of low viscous dextran in the early postoperative period. Acta Chir Scand 122 (1961) 333
58. Arturson G., and Wallenius G. The renal clearance of dextran of different molecular sizes in normal humans. Scand J Clin Lab Invest 16 (1964) 81
59. Nearman H.S., and Herman M.L. Toxic effects of colloids in the intensive care unit. Crit Care Clin 7 (1991) 713
60. Zwaveling J.H., Meulenbelt J., van Xanten N.H.W., and Hené R.J. Renal failure associated with the use of dextran-40. Neth J Med 35 (1989) 321
61. Hardin C.K., Kirk W.C., and Pederson W.C. Osmotic complications of low-molecular weight dextran therapy in free flap surgery. Microsurgery 13 (1992) 36
62. Gunnar W.P., Merlotti G.J., Barret J., and Jonasson O. Resusitation from hemorrhagic shock. Alterations of the intracranial pressure after normal saline, 3% saline and dextran-40. Ann Surg 204 (1986) 686
63. Vos S.C.B., Hage J.J., Woerdeman L.A.E., and Noordanus R.P. Acute renal failure during Dextran 40 antithrombotic prophylaxis. report of tow microsurgical cases. Ann Plast Surg 48 (2002) 193
64. Brookes D., Okeefe P., and Buncke H.J. Dextran-induced acute failure after microvascular muscle transplantation. Plast Reconstr Surg 108 (2001) 2057
65. Schwarz J., Ihle B., and Dowling J. Acute renal failure induced by low molecular-weight dextran. Aust N Z J Med 14 (1984) 688
66. Druml W., and Polzeleitner D. Dextran 40, acute renal failure and elevated plasma oncotic pressure. N Engl J Med 318 (1988) 252
67. Disa J.J., Polvora V.P., and Cordeiro P.G. Dextran-related complications in head and neck microsurgery: do the benefits outweigh the risks? A prospective randomized analysis. Plast Reconstr Surg 112 (2003) 1534
68. Undas A., Brummel K., Musial J., Mann K.G., and Szczeklik A. Blood coagulation at the site of microvascular injury. effects of low-dose aspirin. Blood 98 (2001) 2423
69. Cooley B.C., and Gould J.S. Experimental models for evaluating antithrombotic therapies in replantation microsurgery. Microsurgery 8 (1987) 230
70. Buckley R.C., Davidson S.F., and Das S.K. The role of various antithrombotic agents in microvascular surgery. Br J Plast Surg 47 (1994) 20
71. Salemark L., Wieslander J.B., Dougan P., and Arnljots B. Effects of low and ultra low oral doses of acetylsalicylic acid in microvascular surgery. An experimental study in rabbit. Scand J Plast Reconstr Surg Hand Surg 25 (1991) 203
72. Bannister C.M., and Chapman S.A. The influence of systemic aspirin on rat small diameter vein grafts. a scanning electron microscopic study. Surg Neurol 13 (1980) 99
73. Basile A.P., Fiala T.G., Yaremchuk M.J., and May Jr. J.W. The antithrombotic effects of ticlopidine and aspirin in a microvascular thrombogenic model. Plast Reconstr Surg 95 (1995) 1258
74. Peter F.W., Franken R.J.P.M., Wang W.Z., Anderson G.L., Schuschke D.A., O'Shaughnessy M.M., et al. Effects of low dose aspirin on thrombus formation at arterial and venous microanastomosis and on the tissue microcirculation. Plast Reconstr Surg 99 (1997) 1112
75. Patrono C. Acetylsalicylic acid. In: Messerli F.H. (Ed). Cardiovascular drug therapy. 1st ed. (1990), Saunders, Philadelphia
76. Flordal P. Pharmacological prophylaxis of bleeding in surgical patients treated with aspirin. Eur J Anaesthesiol 14 (1997) 38
77. Peter F.W., Benkovic C., Muehlberger T., Vogt P.M., Homann H.H., Kuhnen C., Wiebalck A., and Steinau H.U. Effects of desmopressin on thrombogenesis in aspirin induced platelet dysfunction. Br J Haematol 117 (2002) 658
78. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van De Putte L.B., and Lipsky P.E. Cyclooxygenase in biology and disease. F. A. S. E. B. J 12 (1998) 1063
79. Fitzmaurice D.A., Blann A.D., and Lip G.Y.H. ABC of antithrombotic therapy. bleeding risks of antithrombotic therapy. BMJ 325 (2002) 828
80. Hawkey C.J. Cox-2 inhibitors. Lancet 353 (1999) 307
81. Jacobs G.R., Reinisch J.F., and Puckett C.L. Microvascular fibrinolysis after ischemia. its relation to vascular patency and tissue survival. Plast Reconstr Surg 68 (1981) 737
82. Cooley B.C., Morgan R.F., and Dellon A.L. Thrombolytic reversal of no-reflow phenomenon in rat free flap model. Surg Forum 34 (1983) 638
83. Yii N.W., Evans G.R.D., Miller M.J., Reece G.P., Langstein H., Chang D., et al. Thrombolytic therapy. what is its role in free flap salvage?. Ann Plast Surg 46 (2001) 601
84. Kroll S.S., Schusterman M.A., Reece G.P., Miller M.J., Evans G.R., Robb G.L., and Baldwin B.J. Choice of flap and incidence of free flap success. Plast Reconstr Surg 98 (1996) 459
85. Schubert W., Hunter D.W., Guzman-Stein G., Ahrenholz D.H., Solem L.D., Dressel T.D., and Cunningham B.L. Use of streptokinase for the salvage of a free flap. case report and review of the use of thrombolytic therapy. Microsurgery 8 (1987) 117
86. Dettelbach H.R., and Aviado D.M. Clinical pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication. J Clin Pharmacol 25 (1985) 8
87. Hayden R.E., and Snyder B.J. Pharmacologic manipulation of random skin flaps with pentoxifylline. Laryngoscope 103 (1993) 185
88. Murthy P., Riesberg M.V., and Civantos F.J. Efficacy of perioperative thromboprophylactic agents in the maintenance of anastomotic patency and survival of rat microvascular free groin flaps. Otolaryngology 129 (2003) 176
89. Walenga J.M., Pifarre R., Hoppensteadt D.A., and Fareed J. Development of recombinant hirudin as a therapeutic anticoagulant and antithrombotic agent. some objective considerations. Semin Thromb Hemost 15 (1989) 316
90. Agnelli G., Renga C., Weitz J.I., Nenci G.G., and Hirsh J. Sustained antithrombotic activity of hirudin after its plasma clearance. comparison with heparin. Blood 80 (1992) 960
91. Broze Jr. G.J., Warren L.A., Novotny W.F., Higuchi D.A., Girard J.J., and Miletich J.P. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa. insight into its possible mechanism of action. Blood 71 (1988) 335
92. Khouri R.K., Koudsi B., Kaiding F., Ornberg R.L., and Wun T.C. Prevention of thrombosis by topical application of tissue factor pathway inhibitor in a rabbit model of vascular trauma. Ann Plast Surg 30 (1993) 398
93. Lan M., Li X.L., Cooley B.C., and Gould J.S. Microvascular salvage procedures with adjuvant antithrombotic therapy for restitution of patency in a rat model. J Reconstr Microsurg 8 (1992) 201
94. Nichter L.S., and Bindiger A. Improving micrograft patency. Microsurgery 9 (1988) 235
95. Concannon M.J., Meng L., Welsh C.F., and Puckett C.L. Inhibition of perioperative platelet aggregation using toradol (ketorolac). Ann Plast Surg 30 (1993) 264
96. Harashina T. Analysis of 200 free flaps. Br J Plast Surg 41 (1988) 33
97. Olsson E., Svartling N., Asko-Seljavaara S., and Lassila R. Activation of coagulation and fibrinolysis in microsurgical reconstructions in the lower extremities. Br J Plast Surg 54 (2001) 597-603
98. Conrad M.H., and Adams Jr. W.P. Pharmacologic optimization of microsurgery in the new millennium. Plast Reconstr Surg 108 (2001) 2088
99. Pederson W.C. Replantation. Plast Reconstr Surg 107 (2001) 823
100. Chen L.E., Seaber A.V., Korompilias A.V., and Urbaniak J.R. Effects of enoxaparin, standard heparin, and streptokinase on the patency of anastomoses in severely crushed arteries. Microsurgery 16 (1995) 661